nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute antibiotic use in cystic fibrosis clinical trials: does it affect our assessment of clinical efficacy?
|
Mayer-Hamblett, Nicole |
|
2013 |
1 |
2 |
p. 98-99 2 p. |
artikel |
2 |
A new Clinical Trials Directive to boost academic trials?
|
De Boeck, Kris |
|
2013 |
1 |
2 |
p. 99-101 3 p. |
artikel |
3 |
A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect
|
Boyle, Michael P |
|
2013 |
1 |
2 |
p. 158-163 6 p. |
artikel |
4 |
Asthma in the global NCD agenda: a neglected epidemic
|
Pearce, Neil |
|
2013 |
1 |
2 |
p. 96-98 3 p. |
artikel |
5 |
Bronchiolitis: have the guts
|
van Woensel, JBM |
|
2013 |
1 |
2 |
p. 92-93 2 p. |
artikel |
6 |
Corrections
|
|
|
2013 |
1 |
2 |
p. 101- 1 p. |
artikel |
7 |
Corrections
|
|
|
2013 |
1 |
2 |
p. 101- 1 p. |
artikel |
8 |
Diana Bilton: a pioneer in cystic fibrosis
|
Akkermans, Rebecca |
|
2013 |
1 |
2 |
p. 112- 1 p. |
artikel |
9 |
Early lung disease in cystic fibrosis
|
Grasemann, Hartmut |
|
2013 |
1 |
2 |
p. 148-157 10 p. |
artikel |
10 |
Foreverland
|
Burki, Talha Khan |
|
2013 |
1 |
2 |
p. 110- 1 p. |
artikel |
11 |
Greenpeace highlights concerns over coal-fired plants in India
|
Burki, Talha Khan |
|
2013 |
1 |
2 |
p. 105- 1 p. |
artikel |
12 |
How should you screen newborn babies for cystic fibrosis?
|
Dehnel, Tim |
|
2013 |
1 |
2 |
p. 108-109 2 p. |
artikel |
13 |
How the airway smooth muscle in cystic fibrosis reacts in proinflammatory conditions: implications for airway hyper-responsiveness and asthma in cystic fibrosis
|
McCuaig, Sarah |
|
2013 |
1 |
2 |
p. 137-147 11 p. |
artikel |
14 |
Longitudinal quantitative low-dose CT in COPD: ready for use?
|
Kauczor, Hans-Ulrich |
|
2013 |
1 |
2 |
p. 95-96 2 p. |
artikel |
15 |
Management of comorbidities in older patients with cystic fibrosis
|
Plant, Barry J |
|
2013 |
1 |
2 |
p. 164-174 11 p. |
artikel |
16 |
Nasogastric hydration versus intravenous hydration for infants with bronchiolitis: a randomised trial
|
Oakley, Ed |
|
2013 |
1 |
2 |
p. 113-120 8 p. |
artikel |
17 |
New cystic fibrosis drug paves the way for orphan diseases
|
Cooney, David |
|
2013 |
1 |
2 |
p. 104- 1 p. |
artikel |
18 |
NICE guidance on colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis
|
Nolan, Kay |
|
2013 |
1 |
2 |
p. 102-103 2 p. |
artikel |
19 |
Not just hot air
|
Burki, Talha Khan |
|
2013 |
1 |
2 |
p. 107- 1 p. |
artikel |
20 |
Surging forwards with cystic fibrosis care
|
The Lancet Respiratory Medicine, |
|
2013 |
1 |
2 |
p. 91- 1 p. |
artikel |
21 |
The coal epidemic
|
Cogliano, Vincent |
|
2013 |
1 |
2 |
p. 111- 1 p. |
artikel |
22 |
The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study
|
Taylor-Robinson, David C |
|
2013 |
1 |
2 |
p. 121-128 8 p. |
artikel |
23 |
The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study
|
Coxson, Harvey O |
|
2013 |
1 |
2 |
p. 129-136 8 p. |
artikel |
24 |
The UK walks the walk in the war against tobacco
|
Senior, Kathryn |
|
2013 |
1 |
2 |
p. 106- 1 p. |
artikel |
25 |
Wealth as a disease modifier in cystic fibrosis
|
Schechter, Michael S |
|
2013 |
1 |
2 |
p. 93-95 3 p. |
artikel |